BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin Y, Lin G, Fang W, Zhu H, Chu K. Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype. Med Oncol 2014;31:327. [PMID: 25412936 DOI: 10.1007/s12032-014-0327-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Wang Z, Lu T, Li Y, Pan M, Yu D, Hu G. Expression and Functional Relevance of ANXA1 in Hypopharyngeal Carcinoma with Lymph Node Metastasis. Onco Targets Ther 2021;14:1387-99. [PMID: 33658802 DOI: 10.2147/OTT.S292287] [Reference Citation Analysis]
2 Raulf N, Lucarelli P, Thavaraj S, Brown S, Vicencio JM, Sauter T, Tavassoli M. Annexin A1 regulates EGFR activity and alters EGFR-containing tumour-derived exosomes in head and neck cancers. Eur J Cancer 2018;102:52-68. [PMID: 30142511 DOI: 10.1016/j.ejca.2018.07.123] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
3 Alli-Shaik A, Wee S, Lim LHK, Gunaratne J. Phosphoproteomics reveals network rewiring to a pro-adhesion state in annexin-1-deficient mammary epithelial cells. Breast Cancer Res 2017;19:132. [PMID: 29233185 DOI: 10.1186/s13058-017-0924-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li P, Li L, Li Z, Wang S, Li R, Zhao W, Feng Y, Huang S, Li L, Qiu H, Xia S. Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway. Cancer Cell Int 2022;22:7. [PMID: 34991599 DOI: 10.1186/s12935-021-02427-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhuang C, Wang P, Sun T, Zheng L, Ming L. Expression levels and prognostic values of annexins in liver cancer. Oncol Lett. 2019;18:6657-6669. [PMID: 31807177 DOI: 10.3892/ol.2019.11025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
6 Cai T, Guan X, Wang H, Fang Y, Long J, Xie X, Zhang Y. MicroRNA-26a regulates ANXA1, rather than DAL-1, in the development of lung cancer. Oncol Lett 2018;15:5893-902. [PMID: 29552220 DOI: 10.3892/ol.2018.8048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Dora D, Rivard C, Yu H, Pickard SL, Laszlo V, Harko T, Megyesfalvi Z, Dinya E, Gerdan C, Szegvari G, Hirsch FR, Dome B, Lohinai Z. Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer. Biology (Basel) 2021;10:502. [PMID: 34200100 DOI: 10.3390/biology10060502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lippolis R, Gnocchi D, Santacroce L, Siciliano RA, Mazzeo MF, Scacco S, Sabbà C, Mazzocca A. A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells. Biochem Biophys Res Commun 2020;526:1150-6. [PMID: 32321639 DOI: 10.1016/j.bbrc.2020.04.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Foo SL, Yap G, Cui J, Lim LH. Annexin-A1 – A Blessing or a Curse in Cancer? Trends in Molecular Medicine 2019;25:315-27. [DOI: 10.1016/j.molmed.2019.02.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
10 Fang Y, Guan X, Cai T, Long J, Wang H, Xie X, Zhang Y. Knockdown of ANXA1 suppresses the biological behavior of human NSCLC cells in vitro. Mol Med Rep. 2016;13:3858-3866. [PMID: 27035116 DOI: 10.3892/mmr.2016.5022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
11 Chen P, Min J, Wu H, Zhang H, Wang C, Tan G, Zhang F. Annexin A1 is a potential biomarker of bone metastasis in small cell lung cancer. Oncol Lett 2021;21:141. [PMID: 33552260 DOI: 10.3892/ol.2020.12402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Deng C, Liu X, Zhang C, Li L, Wen S, Gao X, Liu L. ANXA1-GSK3β interaction and its involvement in NSCLC metastasis. Acta Biochim Biophys Sin (Shanghai) 2021;53:912-24. [PMID: 34002210 DOI: 10.1093/abbs/gmab067] [Reference Citation Analysis]
13 Ju L, Zhu L, Wu H, Yu M, Yin X, Jia Z, Feng L, Ying S, Xia H, Zhang S, Lou J, Yang J. miR221 regulates cell migration by targeting annexin a1 expression in human mesothelial MeT-5A cells neoplastic-like transformed by multi-walled carbon nanotube. Genes Environ 2021;43:34. [PMID: 34340715 DOI: 10.1186/s41021-021-00209-y] [Reference Citation Analysis]
14 Wang X, Zhi Q, Liu S, Xue SL, Shen C, Li Y, Wu C, Tang Z, Chen W, Song JL, Bao M, Song YH, Zhou J. Identification of specific biomarkers for gastric adenocarcinoma by ITRAQ proteomic approach. Sci Rep 2016;6:38871. [PMID: 27941907 DOI: 10.1038/srep38871] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
15 Bavi R, Hang Z, Banerjee P, Aquib M, Jadhao M, Rane N, Bavi S, Bhosale R, Kodam K, Jeon BH, Gu Y. Doxorubicin-Conjugated Innovative 16-mer DNA Aptamer-Based Annexin A1 Targeted Anti-Cancer Drug Delivery. Mol Ther Nucleic Acids 2020;21:1074-86. [PMID: 32854062 DOI: 10.1016/j.omtn.2020.07.038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Chuang MC, Lung JH, Chen YC, Lin YC, Li YC, Hung MS. The Association of Annexin A1 and Chemosensitivity to Osimertinib in Lung Cancer Cells. Cancers (Basel) 2021;13:4106. [PMID: 34439260 DOI: 10.3390/cancers13164106] [Reference Citation Analysis]
17 Okuno T, Kakehashi A, Ishii N, Fujioka M, Gi M, Wanibuchi H. mTOR Activation in Liver Tumors Is Associated with Metabolic Syndrome and Non-Alcoholic Steatohepatitis in Both Mouse Models and Humans. Cancers (Basel) 2018;10:E465. [PMID: 30469530 DOI: 10.3390/cancers10120465] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
18 Zhao X, Ma W, Li X, Li H, Li J, Li H, He F. ANXA1 enhances tumor proliferation and migration by regulating epithelial-mesenchymal transition and IL-6/JAK2/STAT3 pathway in papillary thyroid carcinoma. J Cancer 2021;12:1295-306. [PMID: 33531975 DOI: 10.7150/jca.52171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Han G, Lu K, Huang J, Ye J, Dai S, Ye Y, Zhang L. Effect of Annexin A1 gene on the proliferation and invasion of esophageal squamous cell carcinoma cells and its regulatory mechanisms. Int J Mol Med 2017;39:357-63. [PMID: 28035369 DOI: 10.3892/ijmm.2016.2840] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
20 Wei D, Zeng Y, Xing X, Liu H, Lin M, Han X, Liu X, Liu J. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics. J Proteome Res 2016;15:487-98. [PMID: 26709725 DOI: 10.1021/acs.jproteome.5b00838] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
21 Allen KL, Cann J, Zhao W, Peterson N, Lazzaro M, Zhong H, Wu H, Dall'Acqua WF, Borrok MJ, Damschroder MM, Tsui P, Li Q. Upregulation of annexin A1 protein expression in the intratumoral vasculature of human non-small-cell lung carcinoma and rodent tumor models. PLoS One 2020;15:e0234268. [PMID: 32497150 DOI: 10.1371/journal.pone.0234268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Elakad O, Li Y, Gieser N, Yao S, Küffer S, Hinterthaner M, Danner BC, von Hammerstein-Equord A, Ströbel P, Bohnenberger H. Role of Annexin A1 in Squamous Cell Lung Cancer Progression. Dis Markers 2021;2021:5520832. [PMID: 33959206 DOI: 10.1155/2021/5520832] [Reference Citation Analysis]
23 Wan YM, Tian J, Qi L, Liu LM, Xu N. ANXA1 affects cell proliferation, invasion and epithelial-mesenchymal transition of oral squamous cell carcinoma. Exp Ther Med 2017;14:5214-8. [PMID: 29201239 DOI: 10.3892/etm.2017.5148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
24 Araújo TG, Mota STS, Ferreira HSV, Ribeiro MA, Goulart LR, Vecchi L. Annexin A1 as a Regulator of Immune Response in Cancer. Cells 2021;10:2245. [PMID: 34571894 DOI: 10.3390/cells10092245] [Reference Citation Analysis]
25 Ji L, Wang J, Yang B, Zhu J, Wang Y, Jiao J, Zhu K, Zhang M, Zhai L, Gong T, Sun C, Qin J, Wang G. Urinary protein biomarker panel predicts esophageal squamous carcinoma from control cases and other tumors. Esophagus. [DOI: 10.1007/s10388-022-00932-7] [Reference Citation Analysis]
26 Guan X, Fang Y, Long J, Zhang Y. Annexin 1-nuclear factor-κB-microRNA-26a regulatory pathway in the metastasis of non-small cell lung cancer. Thorac Cancer 2019;10:665-75. [PMID: 30756482 DOI: 10.1111/1759-7714.12982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Shrum B, Costello P, McDonald W, Howlett C, Donnelly M, McAlister VC. In vitro three dimensional culture of hepatocellular carcinoma to measure prognosis and responsiveness to chemotherapeutic agents. Hepatobiliary Surg Nutr 2016;5:204-8. [PMID: 27275461 DOI: 10.21037/hbsn.2016.01.01] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
28 Mordvinov VA, Minkova GA, Kovner AV, Ponomarev DV, Lvova MN, Zaparina O, Romanenko SA, Shilov AG, Pakharukova MY. A tumorigenic cell line derived from a hamster cholangiocarcinoma associated with Opisthorchis felineus liver fluke infection. Life Sci 2021;277:119494. [PMID: 33862109 DOI: 10.1016/j.lfs.2021.119494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]